跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 8,765 条关于
“RAF-MEK”
全部
8,765
临床试验
7,305
药物
888
机构
73
资讯
499
去年
Verastem Oncology to Present New LGSOC Treatment Data at SGO 2025 Annual Meeting
2年前
Nested Therapeutics' NST-628: A Novel Pan-RAF–MEK Molecular Glue for MAPK Pathway Inhibition
去年
Novel Drug Combination Overcomes Resistance in BRAF-Mutated Melanoma, Prevents Brain Metastasis
8个月前
Verastem Discontinues KRAS G12C Trial to Focus on Promising G12D Inhibitor with 69% Response Rate
2年前
Verastem Oncology's Avutometinib and Defactinib Combination Receives FDA Priority Review for Recurrent KRAS Mutant LGSOC
去年
Verastem's Avutometinib and Defactinib Combination Receives FDA Priority Review for Recurrent KRAS Mutant Low-Grade Serous Ovarian Cancer
去年
Verastem Oncology Appoints John Hayslip as Chief Medical Officer
去年
Verastem Oncology's RAMP 203 Trial Shows Encouraging Initial Data for Triplet Combination in Advanced KRAS G12C Mutant NSCLC
2年前
FDA Awards Orphan Drug Designation to Avutometinib Plus Defactinib for Pancreatic Cancer Treatment
去年
Verastem Oncology Seeks FDA Approval for Avutometinib and Defactinib Combination in Low-Grade Serous Ovarian Cancer
第 1 页,共 50 页
上一页
下一页